Literature DB >> 15337571

The importance of postoperative CT image fusion verification of stereotactic interstitial irradiation for brain tumors.

Arpad Viola1, Tibor Major, Jeno Julow.   

Abstract

PURPOSE: The aim of our study was verification of the position of implanted catheters with (125)I seeds after the catheter implantation for the brachytherapy of brain tumors. METHODS AND MATERIALS: The fusion of the CT image used at planning and after the implantation of the catheters enabled us to verify the position of the catheters containing the isotopes. After this, the tumor volume covered by the prescribed dose (TV(PD)) and the normal tissue volume covered by the prescribed dose (NTV(PD)) were compared between the plan and the actual result. The image fusion was performed by the BrainLab-Target 1.19 software on an Alfa 430 (Digital) workstation.
RESULTS: The position of the catheters was adjusted in 14 (20%) of the 70 image fusion cases being studied. The position of 16 of the 116 catheters (13.8%) required adjustment after the fusion of control images in the 70 cases studied. The Student t probe revealed a significant difference between the TV(PD) values of the reality and the plans (75.8% vs. 92.4%, p < 0.0001). There was a significant difference between values of the real performances and planning for NTV(PD) (86.8% vs. 76%, p = 0.001) and for the conformity index (0.37 vs. 0.54, p = 0.0001), too.
CONCLUSION: The application of the interstitial irradiation with CT control allows us to identify and correct possible inaccuracies in catheter positioning during the operation. The procedure then becomes far more accurate and reliable, and as such, the irradiation becomes more conformal than without catheter adjustment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15337571     DOI: 10.1016/j.ijrobp.2004.04.045

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  4 in total

Review 1.  Iodine-125 brachytherapy for brain tumours--a review.

Authors:  Silke B Schwarz; Niklas Thon; Katharina Nikolajek; Maximilian Niyazi; Joerg-Christian Tonn; Claus Belka; Friedrich-Wilhelm Kreth
Journal:  Radiat Oncol       Date:  2012-03-06       Impact factor: 3.481

2.  Value of CT-MRI fusion in iodine-125 brachytherapy for high-grade glioma.

Authors:  Yang Gao; Yan Han; Guo Nan; Man Hu; Xiaobin Zhou; Xiaokun Hu
Journal:  Oncotarget       Date:  2017-12-01

3.  A novel three-dimensional template combined with MR-guided 125I brachytherapy for recurrent glioblastoma.

Authors:  Xiangmeng He; Ming Liu; Menglong Zhang; Roberto Blanco Sequeiros; Yujun Xu; Ligang Wang; Chao Liu; Qingwen Wang; Kai Zhang; Chengli Li
Journal:  Radiat Oncol       Date:  2020-06-08       Impact factor: 3.481

4.  An open-label, single-arm pilot study of EUS-guided brachytherapy with phosphorus-32 microparticles in combination with gemcitabine +/- nab-paclitaxel in unresectable locally advanced pancreatic cancer (OncoPaC-1): Technical details and study protocol.

Authors:  Manoop S Bhutani; Jason B Klapman; Richard Tuli; Ghassan El-Haddad; Sarah Hoffe; Franklin C L Wong; Beth Chasen; David R Fogelman; Simon K Lo; Nicholas N Nissen; Andrew E Hendifar; Gauri Varadhachary; Matthew H G Katz; William D Erwin; Eugene J Koay; Eric P Tamm; Ben S Singh; Rutika Mehta; Robert A Wolff; Ashish Soman; Irina M Cazacu; Joseph M Herman
Journal:  Endosc Ultrasound       Date:  2020 Jan-Feb       Impact factor: 5.628

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.